ArticleMolecular therapy. Oncology2024

TheraVision: Engineering platform technology for the development of oncolytic viruses based on herpes simplex virus type 1.

Christina Funk et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.